Capital Asset Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Capital Asset Advisory Services's VRTX Position: Q2 2026 in Review
Capital Asset Advisory Services increased its Vertex Pharmaceuticals (VRTX) stake by 112% in Q2 2026, buying an estimated $251K and bringing the position to 1,074 shares worth $533K. The position accounts for 0.02% of the portfolio, ranked #197.
Capital Asset Advisory Services first reported a position in VRTX in Q4 2020 and has held it in 6 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Capital Asset Advisory Services held 1,074 shares of Vertex Pharmaceuticals worth $533K as of Q2 2026.
- Capital Asset Advisory Services bought 567 Vertex Pharmaceuticals shares in Q2 2026, an estimated $251K.
- Vertex Pharmaceuticals made up 0.02% of Capital Asset Advisory Services's portfolio in Q2 2026, its #197 holding.
- Capital Asset Advisory Services first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 6 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Capital Asset Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.